MedPath

Benzydamine

Generic Name
Benzydamine
Brand Names
Pharixia, Tantum
Drug Type
Small Molecule
Chemical Formula
C19H23N3O
CAS Number
642-72-8
Unique Ingredient Identifier
4O21U048EF

Overview

Benzydamine (also known as Tantum Verde or Difflam), available as the hydrochloride salt, is a locally-acting nonsteroidal anti-inflammatory drug (NSAID) with local anaesthetic and analgesic properties. It is used topically for pain relief and anti-inflammatory treatment of the mouth, throat, or muscoskeletal system. Although the indazole analogue benzydamine is a non-steroidal anti-inflammatory drug (NSAID), it has various physicochemical properties and pharmacologic activities that are different from those of traditional aspirin-like NSAIDs but facilitate benzydamine's mechanism of action as an effective locally-acting NSAID with local anaesthetic and analgesic properties. Moreover, unlike aspirin-like NSAIDs which are acids or metabolised to acids, benzydamine is in fact a weak base.

Indication

Available predominantly as a liquid mouthwash, oromucosal spray, or topical cream, benzydamine is most frequently employed as a locally acting analgesic and anti-inflammatory treatment for the relief of painful inflammatory conditions. When formulated as a mouthwash or spray, benzydamine may be used to treat traumatic conditions like pharyngitis following tonsillectomy or the use of a naso-gastric tube, inflammatory conditions like pharyngitis, aphthous ulcers and oral ulceration due to radiation therapy, dentistry operations and procedures, or more general conditions like sore throat, sore tongue, sore gums, mouth ulcers, or discomfort caused by dentures. When used as a topical cream, benzydamine may be employed to relieve symptoms associated with painful inflammatory conditions of the muscolo-skeletal system including acute inflammatory disorders such as myalgia and bursitis or traumatic conditions like sprains, strains, bruises, sore muscles, stiff joints, or even the after-effects of fractures.

Associated Conditions

  • Acute Sore Throat
  • Gingivitis
  • Inflammation of Mouth
  • Laryngitis
  • Mouth irritation
  • Mucositis of the oro-pharyngeal
  • Pain
  • Pain, Orofacial
  • Pharyngitis
  • Sore gums
  • Throat irritation
  • Traumatic Injuries caused by Dental Prosthesis
  • Gum irritation

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/11/06
Early Phase 1
Not yet recruiting
KK Women's and Children's Hospital
2022/04/25
Phase 4
UNKNOWN
Rehman Medical Institute - RMI
2022/04/21
Phase 1
ENROLLING_BY_INVITATION
2022/04/12
Phase 2
UNKNOWN
2021/09/24
Phase 4
Completed
Aziende Chimiche Riunite Angelini Francesco S.p.A
2021/06/28
Phase 4
Completed
Aziende Chimiche Riunite Angelini Francesco S.p.A
2019/11/19
Not Applicable
Completed
2018/11/19
Phase 4
Completed
Near East University, Turkey
2017/09/13
Phase 3
Completed
2017/03/09
Phase 4
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
APO-BENZYDAMINE ORAL RINSE
02239044
Mouthwash/Gargle - Buccal
0.15 %
11/9/1998
ODAN-BENZYDAMINE
odan laboratories ltd
02463105
Mouthwash/Gargle - Buccal
0.15 % / W/V
8/11/2017
PMS-BENZYDAMINE
02239537
Mouthwash/Gargle - Buccal
0.15 % / W/V
4/30/1999
RATIO-BENZYDAMINE
ratiopharm inc division of teva canada limited
02230170
Solution - Oral
0.15 %
3/24/1997
PHARIXIA
pendopharm division of pharmascience inc
02229777
Mouthwash/Gargle - Buccal
0.15 % / W/V
12/2/1996
SUN-BENZ - LIQ 0.15%
02226820
Liquid - Dental ,  Oral
.15 %
4/3/1997
NOVO-BENZYDAMINE
novopharm limited
02310422
Mouthwash/Gargle ,  Solution - Buccal ,  Oral
1.5 MG / ML
6/3/2008
NU-BENZYDAMINE ORAL RINSE
nu-pharm inc
02238794
Liquid - Buccal
0.15 %
N/A
PHARIXIA ALCOHOL FREE
pendopharm division of pharmascience inc
02494434
Mouthwash/Gargle - Buccal
0.15 % / W/V
7/13/2020
TANTUM
bausch health, canada inc.
01966065
Mouthwash/Gargle - Buccal
0.15 % / W/V
12/31/1993

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.